Matches in SemOpenAlex for { <https://semopenalex.org/work/W2317552620> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W2317552620 abstract "Disease-modifying drugs (DMDs) have transformed the treatment of relapsing-remitting multiple sclerosis (RRMS). Several studies have shown the benefits of long-term treatment in RRMS; however, all multiple sclerosis (MS) therapies are associated with treatment-related tolerability and safety issues that may challenge patient compliance with therapy. Tolerability issues include flulike symptoms and injection-site reactions for interferon β(IFNβ) and lipoatrophy and systemic postinjection reactions for glatiramer acetate (GA). Altered blood cell counts, depression, and elevated liver enzymes, including rare cases of acute liver injury, are safety issues that have been associated with IFNβand, rarely, systemic anaphylactoid reactions with glatiramer acetate. Common tolerability issues associated with natalizumab are hypersensitivity and postinfusion reactions, and mitoxantrone may cause amenorrhea, nausea, and alopecia. Serious safety issues that have limited the use of natalizumab and mitoxantrone as first-line treatments are progressive multifocal leukoencephalopathy for natalizumab and cardiotoxicity and leukemia for mitoxantrone. Although both tolerability and safety issues can affect patient adherence to therapy, numerous strategies are available to manage tolerability and monitor safety issues. Through careful monitoring of treatment-related safety issues, patient education, and tolerability management strategies, treatment nonadherence can be minimized, thereby maximizing the treatment benefits of DMDs." @default.
- W2317552620 created "2016-06-24" @default.
- W2317552620 creator A5026048764 @default.
- W2317552620 creator A5038384028 @default.
- W2317552620 creator A5048931928 @default.
- W2317552620 creator A5067690675 @default.
- W2317552620 creator A5089265640 @default.
- W2317552620 date "2008-01-01" @default.
- W2317552620 modified "2023-10-16" @default.
- W2317552620 title "Review: Optimizing Adherence to Multiple Sclerosis Therapies" @default.
- W2317552620 doi "https://doi.org/10.7224/1537-2073-10.4.113" @default.
- W2317552620 hasPublicationYear "2008" @default.
- W2317552620 type Work @default.
- W2317552620 sameAs 2317552620 @default.
- W2317552620 citedByCount "11" @default.
- W2317552620 countsByYear W23175526202012 @default.
- W2317552620 countsByYear W23175526202013 @default.
- W2317552620 countsByYear W23175526202014 @default.
- W2317552620 countsByYear W23175526202016 @default.
- W2317552620 countsByYear W23175526202018 @default.
- W2317552620 countsByYear W23175526202020 @default.
- W2317552620 countsByYear W23175526202021 @default.
- W2317552620 crossrefType "journal-article" @default.
- W2317552620 hasAuthorship W2317552620A5026048764 @default.
- W2317552620 hasAuthorship W2317552620A5038384028 @default.
- W2317552620 hasAuthorship W2317552620A5048931928 @default.
- W2317552620 hasAuthorship W2317552620A5067690675 @default.
- W2317552620 hasAuthorship W2317552620A5089265640 @default.
- W2317552620 hasBestOaLocation W23175526201 @default.
- W2317552620 hasConcept C126322002 @default.
- W2317552620 hasConcept C197934379 @default.
- W2317552620 hasConcept C203014093 @default.
- W2317552620 hasConcept C2776694085 @default.
- W2317552620 hasConcept C2778375690 @default.
- W2317552620 hasConcept C2778577042 @default.
- W2317552620 hasConcept C2780580376 @default.
- W2317552620 hasConcept C2780640218 @default.
- W2317552620 hasConcept C2780923524 @default.
- W2317552620 hasConcept C2781004633 @default.
- W2317552620 hasConcept C71924100 @default.
- W2317552620 hasConcept C98274493 @default.
- W2317552620 hasConceptScore W2317552620C126322002 @default.
- W2317552620 hasConceptScore W2317552620C197934379 @default.
- W2317552620 hasConceptScore W2317552620C203014093 @default.
- W2317552620 hasConceptScore W2317552620C2776694085 @default.
- W2317552620 hasConceptScore W2317552620C2778375690 @default.
- W2317552620 hasConceptScore W2317552620C2778577042 @default.
- W2317552620 hasConceptScore W2317552620C2780580376 @default.
- W2317552620 hasConceptScore W2317552620C2780640218 @default.
- W2317552620 hasConceptScore W2317552620C2780923524 @default.
- W2317552620 hasConceptScore W2317552620C2781004633 @default.
- W2317552620 hasConceptScore W2317552620C71924100 @default.
- W2317552620 hasConceptScore W2317552620C98274493 @default.
- W2317552620 hasLocation W23175526201 @default.
- W2317552620 hasOpenAccess W2317552620 @default.
- W2317552620 hasPrimaryLocation W23175526201 @default.
- W2317552620 hasRelatedWork W1589739743 @default.
- W2317552620 hasRelatedWork W1620159237 @default.
- W2317552620 hasRelatedWork W170712426 @default.
- W2317552620 hasRelatedWork W1999046806 @default.
- W2317552620 hasRelatedWork W2008803633 @default.
- W2317552620 hasRelatedWork W2127753286 @default.
- W2317552620 hasRelatedWork W2241732154 @default.
- W2317552620 hasRelatedWork W2394745865 @default.
- W2317552620 hasRelatedWork W2523231025 @default.
- W2317552620 hasRelatedWork W2181547714 @default.
- W2317552620 isParatext "false" @default.
- W2317552620 isRetracted "false" @default.
- W2317552620 magId "2317552620" @default.
- W2317552620 workType "article" @default.